Metis TechBio's AI-Driven IPO: A New Era in Hong Kong Biotechnology
Metis TechBio, an AI-driven life sciences firm, is making its debut on the Hong Kong Stock Exchange. Following a successful IPO, it raised HK$2.1 billion, setting a new benchmark in AI drug discovery funding. Its innovative nanomaterial platform, NanoForge, has …
Read more →
